Healthway Medical Corporation Ltd
SGX:5NG
Healthway Medical Corporation Ltd
SGX:5NG
Price:
0.047
SGD
Market Cap:
S$213.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Healthway Medical Corporation Ltd
SGX:5NG
|
SG |
|
S
|
Sansure Biotech Inc
SSE:688289
|
CN |
|
Luoniushan Co Ltd
SZSE:000735
|
CN |
|
ITT Inc
NYSE:ITT
|
US |
|
J
|
Jiangyin Hengrun Heavy Industries Co Ltd
SSE:603985
|
CN |
|
L
|
Loop Media Inc
AMEX:LPTV
|
US |
|
H
|
Haily Group Bhd
KLSE:HAILY
|
MY |
|
C
|
Chinese Estates Holdings Ltd
HKEX:127
|
HK |
|
Fulu Holdings Ltd
HKEX:2101
|
CN |
|
First Property Group PLC
LSE:FPO
|
UK |
Balance Sheet
Balance Sheet Decomposition
Healthway Medical Corporation Ltd
Healthway Medical Corporation Ltd
Balance Sheet Decomposition is not available for
Healthway Medical Corporation Ltd
Healthway Medical Corporation Ltd
Balance Sheet
Healthway Medical Corporation Ltd
Healthway Medical Corporation Ltd
Currency: SGD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
1
|
3
|
3
|
8
|
7
|
9
|
10
|
16
|
21
|
|
| Cash |
2
|
1
|
0
|
0
|
8
|
7
|
9
|
10
|
16
|
21
|
|
| Cash Equivalents |
0
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
8
|
0
|
0
|
0
|
31
|
26
|
15
|
18
|
18
|
18
|
|
| Total Receivables |
70
|
0
|
0
|
67
|
15
|
14
|
16
|
13
|
21
|
23
|
|
| Accounts Receivables |
10
|
0
|
0
|
67
|
13
|
14
|
15
|
13
|
21
|
22
|
|
| Other Receivables |
60
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
|
| Inventory |
2
|
0
|
0
|
2
|
3
|
3
|
3
|
3
|
4
|
6
|
|
| Other Current Assets |
1
|
0
|
0
|
0
|
2
|
1
|
1
|
2
|
2
|
1
|
|
| Total Current Assets |
82
|
0
|
0
|
73
|
58
|
52
|
44
|
46
|
60
|
69
|
|
| PP&E Net |
6
|
0
|
0
|
5
|
8
|
7
|
27
|
23
|
22
|
31
|
|
| PP&E Gross |
6
|
0
|
0
|
0
|
8
|
7
|
27
|
23
|
22
|
31
|
|
| Accumulated Depreciation |
8
|
7
|
0
|
0
|
6
|
6
|
26
|
34
|
41
|
27
|
|
| Intangible Assets |
28
|
0
|
0
|
116
|
32
|
33
|
33
|
33
|
33
|
33
|
|
| Goodwill |
95
|
95
|
0
|
0
|
110
|
110
|
112
|
114
|
116
|
123
|
|
| Note Receivable |
0
|
20
|
22
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
2
|
3
|
3
|
2
|
3
|
5
|
|
| Other Assets |
95
|
95
|
0
|
0
|
110
|
110
|
112
|
114
|
116
|
123
|
|
| Total Assets |
230
N/A
|
0
N/A
|
0
N/A
|
194
N/A
|
211
+8%
|
204
-3%
|
221
+8%
|
219
-1%
|
237
+8%
|
261
+10%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
10
|
11
|
24
|
28
|
6
|
7
|
7
|
7
|
11
|
11
|
|
| Accrued Liabilities |
4
|
5
|
0
|
0
|
10
|
11
|
10
|
8
|
9
|
10
|
|
| Short-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
12
|
0
|
0
|
11
|
1
|
0
|
9
|
8
|
8
|
10
|
|
| Other Current Liabilities |
6
|
0
|
0
|
0
|
5
|
3
|
3
|
3
|
5
|
9
|
|
| Total Current Liabilities |
35
|
16
|
24
|
39
|
22
|
22
|
29
|
26
|
34
|
39
|
|
| Long-Term Debt |
4
|
0
|
0
|
3
|
0
|
0
|
13
|
9
|
8
|
12
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
5
|
7
|
|
| Total Liabilities |
40
N/A
|
0
N/A
|
0
N/A
|
43
N/A
|
24
-43%
|
24
-3%
|
44
+85%
|
39
-11%
|
48
+24%
|
61
+27%
|
|
| Equity | |||||||||||
| Common Stock |
204
|
0
|
0
|
208
|
277
|
277
|
277
|
277
|
277
|
278
|
|
| Retained Earnings |
12
|
0
|
0
|
56
|
91
|
97
|
101
|
97
|
89
|
78
|
|
| Unrealized Security Profit/Loss |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Total Equity |
191
N/A
|
0
N/A
|
0
N/A
|
152
N/A
|
186
+23%
|
181
-3%
|
177
-2%
|
181
+2%
|
188
+4%
|
200
+6%
|
|
| Total Liabilities & Equity |
230
N/A
|
0
N/A
|
0
N/A
|
194
N/A
|
211
+8%
|
204
-3%
|
221
+8%
|
219
-1%
|
237
+8%
|
261
+10%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2 308
|
0
|
0
|
2 460
|
4 529
|
4 529
|
4 511
|
4 519
|
4 527
|
4 536
|
|
Switch to:
Switch to:
See Also
Discover More
